Genitourinary System Medications

This tender concerns the procurement of medications for the genitourinary system. The contracting authority is seeking to acquire a range of pharmaceutical products essential for treating conditions affecting the urinary tract and reproductive organs. The scope of the procurement is defined by the reference CP 2023/495. Potential bidders are expected to supply high-quality medications that meet all relevant regulatory standards and specifications. The tender aims to ensure the availability of necessary treatments for patients within the healthcare system. Detailed technical specifications, quantities, and delivery timelines will be provided in the tender documentation. Interested parties should review the full tender package to understand the specific requirements for product registration, quality control, packaging, and supply chain management. This acquisition is crucial for maintaining the continuity of care for patients requiring genitourinary system treatments and ensuring the efficient operation of healthcare services. The contracting authority will evaluate proposals based on criteria such as price, quality, delivery reliability, and compliance with all stipulated requirements.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 74.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.